Over the years, COG has made significant contributions to pediatric oncology. Notable achievements include developing new protocols for the treatment of acute lymphoblastic leukemia (ALL), which has significantly improved survival rates. Additionally, COG research has led to advancements in the treatment of neuroblastoma, resulting in better survival outcomes for high-risk patients. The group has also made strides in reducing long-term side effects of cancer treatment through innovative therapies.
